ERBB4 and esophageal squamous cell carcinoma: In all, 72.5% of the total 40 mutations occurred in extracellular or kinase domain of ErbB4 (Fig. 1d, Supplementary Fig. 4c), suggesting a potential role of ERBB4 in ESCC.